In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best wide moat stocks to invest in. Russell Investments continues to monitor and ...

With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines.

Gilead Sciences (GILD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Gilead Sciences, Inc. (NASDAQ:GILD) is still seeing strong product revenue growth regarding its Covid-19 anti-viral drug Veklury [remdesivir]. This is because in the company's Q3 of 2024 financial ...

A 20-year-old Morrow County woman died following a two-vehicle crash Monday morning on U.S Route 42 in Gilead Township. Summer Kennard of Cardington was transported to Morrow County Hospital in Mt.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...